Company Number: SC761921

Analysis Date: 2025-07-19 12:13 UTC

Financial Health Assessment for AXISWAY LTD

---

1. Financial Health Score: D

Explanation:
AXISWAY LTD currently exhibits signs of financial distress, reflected in negative net assets and working capital. While still operational and compliant with filing deadlines, its balance sheet shows liabilities exceeding assets, which is a critical symptom of financial strain. The company’s early stage (incorporated in 2023) and small size partially mitigate concerns, but immediate attention to cash flow and capital structure is vital.

---

2. Key Vital Signs

Metric	2025 (£)	Interpretation
Current Assets	66	Extremely low; indicates minimal liquid resources available to meet short-term obligations.
Debtors	66	Entire current assets tied up in receivables; no cash or stock buffer observed.
Current Liabilities	300	Substantial short-term debts that far exceed current assets, creating liquidity pressure.
Net Current Assets	-234	Negative working capital – a serious symptom indicating inability to cover immediate debts.
Net Assets	-234	Negative net worth; total liabilities exceed total assets, a key red flag for solvency concerns.
Shareholders’ Funds	-234	Equity is negative, reflecting accumulated losses and capital erosion.
Number of Employees	0	No staff costs, possibly reducing overhead but also limiting operational capacity.

---

3. Diagnosis

AXISWAY LTD’s financial vital signs reveal a company experiencing symptoms of distress typical of a young start-up facing liquidity and solvency challenges:

• Liquidity Crunch: The company’s current liabilities are more than four times its current assets, primarily driven by creditors (£300) versus debtors (£66). The absence of cash or other liquid assets exacerbates the risk of default on short-term obligations.

• Negative Net Worth: Net assets and shareholders’ funds have swung from a positive £100 in 2024 to a negative £234 in 2025. This deterioration signals accumulated losses or capital withdrawals not yet offset by profits or additional capital injection.

• Early Stage Risk: Incorporated in March 2023, AXISWAY is still in its infancy. Initial losses and negative working capital are common, but if prolonged, these symptoms can lead to severe financial distress.

• Operational Scale: With no employees listed, the company may be operating with minimal overhead, possibly relying on the director or outsourcing. This might limit expenses but also constrain growth and revenue generation.

• Compliance: No overdue filings or penalties suggest sound administrative governance, which is a positive sign and allows focus on financial recovery.

---

4. Recommendations

To restore financial health and stabilize the company’s financial “heartbeat,” the following steps are advised:

a. Improve Liquidity:

• Accelerate debtor collections to convert receivables into cash quickly.
• Negotiate extended payment terms with creditors to ease immediate cash outflows.
• Consider short-term financing options (e.g., director loans or overdrafts) to cover working capital gaps.

b. Capital Injection:

• The sole shareholder/director (Mr. Denys Tochylkin) should consider injecting additional equity capital to restore positive net assets and provide a financial buffer.
• Explore external investor interest if feasible, to improve capital structure.

c. Revenue Growth & Cost Control:

• Increase focus on sales and marketing to generate higher revenue streams, leveraging the company’s IT consultancy and web development expertise.
• Maintain tight control on overheads; assess if outsourcing or subcontracting can optimize costs without reducing service quality.

d. Financial Monitoring:

• Implement regular cash flow forecasting and financial reporting to detect early signs of distress.
• Monitor key ratios such as current ratio, quick ratio, and net asset position monthly.

e. Strategic Planning:

• Review business model and pricing strategies for sustainable profitability.
• Consider phased growth aligned with available resources to avoid overextension.

---

Medical Analogy Summary:

AXISWAY LTD’s financial system shows symptoms akin to a patient with low blood pressure and poor circulation — the company’s cash flow and equity are insufficient to sustain the necessary operational “oxygen” (working capital). Immediate intervention to stabilize liquidity and strengthen capital “immune system” is vital to prevent a financial “collapse.” With prompt care and monitoring, recovery is possible.

---